Personality traits as a possible factor in the inflammatory response in the first depression episode and in recurrent depressive disorders von Talarowska, M., Bliźniewska, K., Szemraj, J., Kowalczyk, M., Gałecki, P.

Volltext

Auditory-verbal declarative and operating memory among patients suffering from depressive disorders – preliminary study von Talarowska, M, Florkowski, A, Zboralski, K, Berent, D, Wierzbiński, P, Gałecki, P

Volltext

P.0685 Safety assessment of esketamine administration via dry powder inhaler in patients with treatment-resistant bipolar depression von Wieczorek, M., Janowska, S., Gałecki, P.

Volltext

P.0687 Safety assessment of esketamine administered via dry powder inhaler in patients with treatment-resistant major depression von Janowska, S., Wieczorek, M., Gałecki, P.

Volltext

Will genetic polymorphism of tetranucleotide sequences help in the diagnostics of major psychiatric disorders? von Jacewicz, R., Szram, S., Gałecki, P., Berent, J.

Volltext

Disease-drug database for pharmacogenomic-based prescribing von Hussain, S, Kenigsberg, BB, Danahey, K, Lee, YM, Galecki, PM, Ratain, MJ, O'Donnell, PH

Volltext

S.18.02 Functional polymorphisms in oxidative and nitrosative stress genes von Galecki, P

Volltext

Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program von McKillip, RP, Borden, BA, Galecki, P, Ham, SA, Patrick‐Miller, L, Hall, JP, Hussain, S, Danahey, K, Siegler, M, Sorrentino, MJ, Sacro, Y, Davis, AM, Rubin, DT, Lipstreuer, K, Polonsky, TS, Nanda, R, Harper, WR, Koyner, JL, Burnet, DL, Stadler, WM, Ratain, MJ, Meltzer, DO, O'Donnell, PH

Volltext

P.2.b.001 Acetylserotonin methyltransferase gene expression correlates with cognitive impairment in recurrent depressive disorder – preliminary study von Talarowska, M, Galecki, P

Volltext

The impact of cancer treatment on cognitive efficiency von Kuśmierek, M., Jasionowska, J., Maruszewska, P., Kalinka-Warzocha, E., Gałecki, P., Mikołajczyk, I., Talarowska, M.

Volltext

P.2.b.015 iNOS gene expression correlates with cognitive impairment in recurrent depressive disorder von Talarowska, M, Galecki, P

Volltext

P.2.a.006 Oxidative stress and cognitive impairment in patients with recurrent depressive disorder von Talarowska, M, Galecki, P

Volltext

P.2.a.002 Cognitive functions among women and men suffering from depressive disorders von Talarowska, M, Florkowski, A, Galecki, P

Volltext

Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynureni... von Maes, Michael, Galecki, Piotr, Verkerk, Robert, Rief, Winfried

Volltext

P.8.01 Mental retardation – psychopathology, diagnosing and treatment – forty years after Webster's theory von Bobinska, K, Galecki, P, Smigielski, J, Florkowski, A, Szemraj, J

Volltext

P.4.06 Trazodone – efficacious way to treat adjustment disorders von Galecki, P, Bobinska, K, Zboralski, K, Berent, D, Florkowski, A

Volltext

P.2.07 Comparison of the effectiveness of trazodone and venlafaxine therapy in patients with diagnosed depressive disorders von Zboralski, K, Florkowski, A, Talarowska, M, Wysokinski, A, Galecki, P

Volltext

P.2.02 Citalopram and venlafaxine in the treatment of depressive disorder in elderly patients von Galecki, P, Florkowski, A, Jurczyk, A.P, Bobinska, K, Pietras, T, Zboralski, K

Volltext

Single nucleotide polymorphism of the KIBRA gene in recurrent depressive disorders von Galecki, Piotr, Szemraj, Janusz, Florkowski, Antoni, Talarowska, Monika, Bienkiewicz, Malgorzata, Galecka, Elzbieta, Lewinski, Andrzej

Volltext

Relation between functional polymorphism of catalase gene (-262C>T) and recurrent depressive disorder von Galecki, Piotr, Szemraj, Janusz, Zboralski, Krzysztof, Florkowski, Antoni, Lewinski, Andrzej

Volltext